Additionally, the ROC analysis confirmed that the expression of BCL2A1 and CEBPB were of great diagnostic value in IBD and Sepsis (Figure 7B,D) and (Figure S7B). This evidence concerns the gene CEBPB and inflammatory bowel disease.